# A Study to Treat Patients Whose Chronic Angina Symptoms Are Not Relieved by Medication and Have an Area of the Heart That Cannot be Treated by Standard Therapies

> **NCT00215696** · PHASE2 · COMPLETED · sponsor: **GenVec** · enrollment: 129 (—)

## Conditions studied

- Moderate to Severe Angina Pectoris

## Interventions

- **GENETIC:** BioBypass®

## Key facts

- **NCT ID:** NCT00215696
- **Lead sponsor:** GenVec
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-04
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 129 (—)
- **Last updated:** 2011-05-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00215696

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00215696, "A Study to Treat Patients Whose Chronic Angina Symptoms Are Not Relieved by Medication and Have an Area of the Heart That Cannot be Treated by Standard Therapies". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00215696. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*